Belatacept Liquid
NDC Package 71124-0040-0
Package Information
Belatacept liquids is belatacept is used to help prevent organ rejection in people who have received a kidney transplant. This formulation utilizes a liquid delivery system. Marketed by Samsung Biologics Co., Ltd., this product is identified by NDC 71124-0040.
Identification & Billing
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 71124 - Samsung Biologics Co., Ltd.
- 71124-0040 -
- 71124-0040-0 - 10.25 kg in 1 BOTTLE
- 71124-0040 -
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (71124-0040). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 71124-0040-0 identifies a specific commercial package of 10.25 kg in 1 bottle of Belatacept (UNFINISHED drug), a bulk ingredient labeled by Samsung Biologics Co., Ltd.. This liquid is formulated for use and contains belatacept as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Samsung Biologics Co., Ltd. on December 29, 2022. The current certification is valid through December 31, 2027.
What are the primary indications for this medication?
Belatacept is used to help prevent organ rejection in people who have received a kidney transplant. It is used along with other medications (such as mycophenolate, corticosteroids) to allow your new organ to function normally. Belatacept belongs to a class of drugs known as immunosuppressants. It works by weakening your body's natural defense (immune system) to prevent your body from rejecting the new kidney.
How is this Samsung Biologics Co., Ltd. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 71124004000. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.